Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU
Filament Health Corp. (OTCQB: FLHLF) and Psyence Group Inc. (OTCQB: PSYGF) have inked a worldwide commercial licensing deal.
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
Part one of a three-part series.
The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal’s Decrim Project
Psychedelic Research & Fed Funding By The National Institute Of Mental Health
The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants.
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics
Filament Health Shares Q3 2022 Results, On Road To Becoming Industry’s Natural Psilocybin Supplier
Clinical-stage natural psychedelic drug development company Filament Health Corp. (OTCQB: FLHLF) reported its third quarter financial results and operational highlights for the period ended September 30, 2022.
Psyched: Brock Pierce Joins Psychedelic VC, Colorado’s Psychedelics Legalization, Zappy Zapolin’s Open Letter & More
Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'
EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says ‘Potential Reward Is Immeasurable’
Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a general partner, Benzin
Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin
TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace.
Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs
Clinical-stage natural psychedelics company Filament Health Corp.
Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment.